Rabia Farooquee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rabia Farooquee has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Cara H. Kanner
Department of Rehabilitation and Regenerative Medicine Columbia University Irving Medical Center New York New York USA
3 shared publications - Damiano Zanotto
Department of Mechanical Engineering, Stevens Institute of Technology, Hoboken, USA
3 shared publications - Jacqueline Montes
Department of Rehabilitation and Regenerative Medicine Columbia University Irving Medical Center New York New York USA
3 shared publications - Maria Fragala-Pinkham
Department of Physical Therapy and Occupational Therapy, Boston Children’s Hospital, Boston, MA, USA
3 shared publications - Sally Dunaway Young
Department of Neurology and Clinical Neurosciences Stanford University School of Medicine Stanford California USA
3 shared publications - Ton T. H. Duong
Department of Mechanical Engineering, Stevens Institute of Technology, Hoboken, NJ, USA
3 shared publications
Latest Publications
- Open Access
- 21 September 2026
- Published by Springer Nature in Scientific Reports
Validity of insole-derived spatiotemporal and center-of-pressure metrics in ambulatory Duchenne muscular dystrophy and spinal muscular atrophy
Spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD) are rare, childhood-onset neuromuscular diseases (NMDs) characterized by progressive muscle weakness that frequently leads to loss of ambulation. Although several approved disease-modifying therapies (DMTs)–and others currently under investigation–have shown promising results and significantly altered disease trajectories, the standardized in-clinic assessments commonly used as trial endpoints often fail to capture meaningful real-world mobility improvements reported by treated patients. This gap complicates accurate evaluation of therapeutic efficacy and may contribute to delays in patient access to emerging treatments. Wearable-based gait monitoring offers a practical solution for remotely assessing ambulatory function in individuals with motor impairments. Real-world gait patterns can serve as sensitive functional biomarkers to monitor treatment response and track disease progression. However, most real-world studies on NMDs have focused on volume metrics such as step count, which lack stride-level granularity and cannot capture independent gait domains, or on basic spatiotemporal (SPT) metrics related to pace, rhythm, or variability. Kinetic parameters–such as center-of-pressure (COP)-derived metrics–are critical for assessing dynamic stability and muscle strength deficits in NMDs, yet they remain largely unexplored in real-world settings. Unlike other wearables, instrumented insoles allow for the assessment of both SPT and kinetic parameters, with stride-level granularity. Towards the development of multi-domain functional digital biomarkers for ambulatory NMDs, this study evaluates the construct, concurrent, and known-groups validity of insole-based, stride-level SPT and COP-derived parameters in individuals with DMD and SMA during walking tasks designed to simulate real-world walking. Mean absolute errors (MAEs) relative to gold-standard gait-laboratory equipment were used to assess construct validity, while correlations between insole-based metrics and standardized clinical assessment tests provided proof-of-concept concurrent validity. To establish the added value of COP metrics with respect to known-groups validity, we also conducted a comparative analysis of the ability of insole-based SPT and COP-derived features to discriminate between individuals with DMD or SMA and healthy controls. Results suggest that incorporating COP-derived metrics alongside more conventional SPT measures may help better characterize disease-specific gait signatures and their relationships with functional impairment in ambulatory individuals with DMD and SMA. COP metrics were more informative than SPT measures in DMD, whereas they were largely complementary to SPT measures in SMA, with the anteroposterior range of COP (AP-COP) nonetheless standing out for its associations with lower-limb strength and walking capacity. Overall, this work provides proof-of-concept evidence of the utility of combined SPT and COP gait parameters as candidate functional digital biomarkers in ambulatory NMDs, paving the way for more extensive evaluations in free-living settings.
- 21 September 2026
- Published by Springer Nature in Scientific Reports
Open AccessValidity of insole-derived spatiotemporal and center-of-pressure metrics in ambulatory Duchenne muscular dystrophy and spinal muscular atrophy
Spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD) are rare, childhood-onset neuromuscular diseases (NMDs) characterized by progressive muscle weakness that frequently leads to loss of ambulation. Although several approved disease-modifying therapies (DMTs)–and others currently under investigation–have shown promising results and significantly altered disease trajectories, the standardized in-clinic assessments commonly used as trial endpoints often fail to capture meaningful real-world mobility improvements reported by treated patients. This gap complicates accurate evaluation of therapeutic efficacy and may contribute to delays in patient access to emerging treatments. Wearable-based gait monitoring offers a practical solution for remotely assessing ambulatory function in individuals with motor impairments. Real-world gait patterns can serve as sensitive functional biomarkers to monitor treatment response and track disease progression. However, most real-world studies on NMDs have focused on volume metrics such as step count, which lack stride-level granularity and cannot capture independent gait domains, or on basic spatiotemporal (SPT) metrics related to pace, rhythm, or variability. Kinetic parameters–such as center-of-pressure (COP)-derived metrics–are critical for assessing dynamic stability and muscle strength deficits in NMDs, yet they remain largely unexplored in real-world settings. Unlike other wearables, instrumented insoles allow for the assessment of both SPT and kinetic parameters, with stride-level granularity. Towards the development of multi-domain functional digital biomarkers for ambulatory NMDs, this study evaluates the construct, concurrent, and known-groups validity of insole-based, stride-level SPT and COP-derived parameters in individuals with DMD and SMA during walking tasks designed to simulate real-world walking. Mean absolute errors (MAEs) relative to gold-standard gait-laboratory equipment were used to assess construct validity, while correlations between insole-based metrics and standardized clinical assessment tests provided proof-of-concept concurrent validity. To establish the added value of COP metrics with respect to known-groups validity, we also conducted a comparative analysis of the ability of insole-based SPT and COP-derived features to discriminate between individuals with DMD or SMA and healthy controls. Results suggest that incorporating COP-derived metrics alongside more conventional SPT measures may help better characterize disease-specific gait signatures and their relationships with functional impairment in ambulatory individuals with DMD and SMA. COP metrics were more informative than SPT measures in DMD, whereas they were largely complementary to SPT measures in SMA, with the anteroposterior range of COP (AP-COP) nonetheless standing out for its associations with lower-limb strength and walking capacity. Overall, this work provides proof-of-concept evidence of the utility of combined SPT and COP gait parameters as candidate functional digital biomarkers in ambulatory NMDs, paving the way for more extensive evaluations in free-living settings.
- 12 September 2026
- Published by Wiley in Muscle & Nerve
- Vol. 74 (5) , 1435-1442
Gait Speed in Spinal Muscular Atrophy: A Key Vital Sign Linked to Strength and Fatigability
Introduction/Aims: Gait Speed (GS), a valid and reliable indicator of function and health in multiple populations, has not been explored in spinal muscular atrophy (SMA). The purpose of this study was to characterize GS and gait speed reserves (GSR), and explore associations with strength and fatigability in SMA and healthy controls (HC). Methods: Data were collected from ambulatory individuals with SMA ( n = 14) and controls (HC) ( n = 10). Using custom‐engineered instrumented insoles, stride velocity (SV) was collected during the Six‐Minute Walk Test (6MWT) and 10‐m walk/run (10MWR). Three GS variables were identified; SV50th Centile 6MWT (SV50C 6MWT ), 10MWR SV, and SV95th Centile 6MWT (SV95C 6MWT ). Gait speed reserve (GSR) was calculated from 10MWR and SV50C 6MWT . Repeated measures analysis of variance assessed differences in GS and GSR across groups. Spearman's Rho was used to assess associations between speed variables and clinical assessments. Results: All speed variables were different within HC ( p < 0.001) and SMA ( p = 0.002). There was a significant Group × Speed interaction ( p < 0.001) with greater differences in HC. GSR was lower in SMA ( p < 0.001, d = 2.42). In SMA, thigh strength was associated with all three GS variables and inversely associated with fatigability ( p < 0.05). In HC, associations between GS and strength or fatigability were not observed. GSR was not associated with strength, fatigability, or GS in either group. Discussion: GS is diminished in SMA and correlated with strength and fatigability. While reduced in SMA, GSR was not associated with GS, strength, or function. GS is a key vital sign of health and may be a useful biomarker in SMA.
- 12 September 2026
- Published by Wiley in Muscle & Nerve
- Vol. 74 (5) , 1435-1442
Gait Speed in Spinal Muscular Atrophy: A Key Vital Sign Linked to Strength and Fatigability
Introduction/Aims: Gait Speed (GS), a valid and reliable indicator of function and health in multiple populations, has not been explored in spinal muscular atrophy (SMA). The purpose of this study was to characterize GS and gait speed reserves (GSR), and explore associations with strength and fatigability in SMA and healthy controls (HC). Methods: Data were collected from ambulatory individuals with SMA ( n = 14) and controls (HC) ( n = 10). Using custom‐engineered instrumented insoles, stride velocity (SV) was collected during the Six‐Minute Walk Test (6MWT) and 10‐m walk/run (10MWR). Three GS variables were identified; SV50th Centile 6MWT (SV50C 6MWT ), 10MWR SV, and SV95th Centile 6MWT (SV95C 6MWT ). Gait speed reserve (GSR) was calculated from 10MWR and SV50C 6MWT . Repeated measures analysis of variance assessed differences in GS and GSR across groups. Spearman's Rho was used to assess associations between speed variables and clinical assessments. Results: All speed variables were different within HC ( p < 0.001) and SMA ( p = 0.002). There was a significant Group × Speed interaction ( p < 0.001) with greater differences in HC. GSR was lower in SMA ( p < 0.001, d = 2.42). In SMA, thigh strength was associated with all three GS variables and inversely associated with fatigability ( p < 0.05). In HC, associations between GS and strength or fatigability were not observed. GSR was not associated with strength, fatigability, or GS in either group. Discussion: GS is diminished in SMA and correlated with strength and fatigability. While reduced in SMA, GSR was not associated with GS, strength, or function. GS is a key vital sign of health and may be a useful biomarker in SMA.
- Open Access
- 30 November 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Neural Systems and Rehabilitation Engineering
- Vol. 31 (15344320) , 4801-4811
Accurate COP Trajectory Estimation in Healthy and Pathological Gait Using Multimodal Instrumented Insoles and Deep Learning Models
Measuring center-of-pressure (COP) trajectories in out-of-the-lab environments may provide valuable information about changes in gait and balance function related to natural disease progression or treatment in neurological disorders. Traditional equipment to acquire COP trajectories includes stationary force plates, instrumented treadmills, electronic walkways, and insoles featuring high-density force sensing arrays, all of which are expensive and not widely accessible. This study introduces novel deep recurrent neural networks that can accurately estimate dynamic COP trajectories by fusing data from affordable and heterogeneous insole-embedded sensors (namely, an eight-cell array of force sensitive resistors (FSRs) and an inertial measurement unit (IMU)). The method was validated against gold-standard equipment during out-of-the-lab ambulatory tasks that simulated real-world walking. Root-mean-square errors (RMSE) in the mediolateral (ML) and anteroposterior (AP) directions obtained from healthy individuals (ML: 0.51 cm, AP: 1.44 cm) and individuals with neuromuscular conditions (ML: 0.59 cm, AP: 1.53 cm) indicated technical validity. In individuals with neuromuscular conditions, COP-derived metrics showed significant correlations with validated clinical measures of ambulatory function and lower-extremity muscle strength, providing proof-of-concept evidence of the convergent validity of the proposed method for clinical applications.
- 30 November 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Neural Systems and Rehabilitation Engineering
- Vol. 31 (15344320) , 4801-4811
Open AccessAccurate COP Trajectory Estimation in Healthy and Pathological Gait Using Multimodal Instrumented Insoles and Deep Learning Models
Measuring center-of-pressure (COP) trajectories in out-of-the-lab environments may provide valuable information about changes in gait and balance function related to natural disease progression or treatment in neurological disorders. Traditional equipment to acquire COP trajectories includes stationary force plates, instrumented treadmills, electronic walkways, and insoles featuring high-density force sensing arrays, all of which are expensive and not widely accessible. This study introduces novel deep recurrent neural networks that can accurately estimate dynamic COP trajectories by fusing data from affordable and heterogeneous insole-embedded sensors (namely, an eight-cell array of force sensitive resistors (FSRs) and an inertial measurement unit (IMU)). The method was validated against gold-standard equipment during out-of-the-lab ambulatory tasks that simulated real-world walking. Root-mean-square errors (RMSE) in the mediolateral (ML) and anteroposterior (AP) directions obtained from healthy individuals (ML: 0.51 cm, AP: 1.44 cm) and individuals with neuromuscular conditions (ML: 0.59 cm, AP: 1.53 cm) indicated technical validity. In individuals with neuromuscular conditions, COP-derived metrics showed significant correlations with validated clinical measures of ambulatory function and lower-extremity muscle strength, providing proof-of-concept evidence of the convergent validity of the proposed method for clinical applications.